{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:49:17Z","timestamp":1791823757651,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["2024AB17049"],"award-info":[{"award-number":["2024AB17049"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2023GXNSFDA026061"],"award-info":[{"award-number":["2023GXNSFDA026061"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"DOI":"10.1007\/s10067-026-08478-0","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:42:02Z","timestamp":1791772922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory and total immunoglobulin biomarker domains in systemic sclerosis vasculopathy: a phenotype-based cross-sectional study"],"prefix":"10.1007","author":[{"given":"Huichen","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daming","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyou","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2221-7740","authenticated-orcid":false,"given":"Ling","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"2","key":"8478_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4078\/jrd.2024.0129","volume":"32","author":"HH Son","year":"2025","unstructured":"Son HH, Moon SJ (2025) Pathogenesis of systemic sclerosis: an integrative review of recent advances. J Rheum Dis 32(2):89\u2013104. https:\/\/doi.org\/10.4078\/jrd.2024.0129","journal-title":"J Rheum Dis"},{"issue":"10373","key":"8478_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","volume":"401","author":"ER Volkmann","year":"2023","unstructured":"Volkmann ER, Andr\u00e9asson K, Smith V (2023) Systemic sclerosis. Lancet 401(10373):304\u2013318. https:\/\/doi.org\/10.1016\/S0140-6736(22)01692-0","journal-title":"Lancet"},{"key":"8478_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1551911","volume":"16","author":"SA Jimenez","year":"2025","unstructured":"Jimenez SA, Mendoza FA, Piera-Velazquez S (2025) A review of recent studies on the pathogenesis of systemic sclerosis: focus on fibrosis pathways. Front Immunol 16:1551911. https:\/\/doi.org\/10.3389\/fimmu.2025.1551911","journal-title":"Front Immunol"},{"key":"8478_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01349-z","author":"JHW Distler","year":"2026","unstructured":"Distler JHW, Launay D, Feghali-Bostwick C et al (2026) Mechanisms of fibrotic tissue remodelling: insights from systemic sclerosis. Nat Rev Rheumatol. https:\/\/doi.org\/10.1038\/s41584-025-01349-z","journal-title":"Nat Rev Rheumatol"},{"issue":"179","key":"8478_CR5","doi-asserted-by":"publisher","first-page":"250137","DOI":"10.1183\/16000617.0137-2025","volume":"35","author":"A Villa","year":"2026","unstructured":"Villa A, Sanges S, Sobanski V et al (2026) Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons. Eur Respir Rev 35(179):250137. https:\/\/doi.org\/10.1183\/16000617.0137-2025","journal-title":"Eur Respir Rev"},{"issue":"3","key":"8478_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jaad.2025.11.060","volume":"94","author":"J Huang","year":"2026","unstructured":"Huang J, Wang X, Han X et al (2026) Pruritic papules in systemic sclerosis is associated with scleroderma renal crisis. J Am Acad Dermatol 94(3):1019\u20131021. https:\/\/doi.org\/10.1016\/j.jaad.2025.11.060","journal-title":"J Am Acad Dermatol"},{"key":"8478_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115282","volume":"166","author":"H Ren","year":"2023","unstructured":"Ren H, Liu L, Xiao Y et al (2023) Further insight into systemic sclerosis from the vasculopathy perspective. Biomed Pharmacother 166:115282. https:\/\/doi.org\/10.1016\/j.biopha.2023.115282","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"8478_CR8","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1007\/s10067-024-07123-y","volume":"43","author":"A Bazs\u00f3","year":"2024","unstructured":"Bazs\u00f3 A, Szodoray P, Shoenfeld Y et al (2024) Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review. Clin Rheumatol 43(10):3055\u20133072. https:\/\/doi.org\/10.1007\/s10067-024-07123-y","journal-title":"Clin Rheumatol"},{"issue":"2","key":"8478_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/BOR.0000000000001063","volume":"37","author":"SD Good","year":"2025","unstructured":"Good SD, Lee JY, Johnson RE et al (2025) A scoping review of the epidemiology of systemic sclerosis and its organ manifestations: 2018\u20132024. Curr Opin Rheumatol 37(2):103\u2013112. https:\/\/doi.org\/10.1097\/BOR.0000000000001063","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"8478_CR10","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/thorax-2023-220820","volume":"78","author":"ER Volkmann","year":"2023","unstructured":"Volkmann ER, Tashkin DP (2023) Outcomes of systemic sclerosis associated interstitial lung disease patients with a persistent inflammatory phenotype based on serial CRP measurements. Thorax 78(12):1166\u20131167. https:\/\/doi.org\/10.1136\/thorax-2023-220820","journal-title":"Thorax"},{"key":"8478_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1438302","volume":"15","author":"AA Mangoni","year":"2024","unstructured":"Mangoni AA, Zinellu A (2024) Circulating cell adhesion molecules in systemic sclerosis: a systematic review and meta-analysis. Front Immunol 15:1438302. https:\/\/doi.org\/10.3389\/fimmu.2024.1438302","journal-title":"Front Immunol"},{"issue":"18","key":"8478_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814385","volume":"24","author":"E Patnaik","year":"2023","unstructured":"Patnaik E, Lyons M, Tran K et al (2023) Endothelial dysfunction in systemic sclerosis. Int J Mol Sci 24(18):14385. https:\/\/doi.org\/10.3390\/ijms241814385","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8478_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-025-03568-x","volume":"27","author":"G Bandini","year":"2025","unstructured":"Bandini G, Bellando Randone S, Manetti M et al (2025) Endotheliopathy in systemic sclerosis: from endothelium-dependent vasodilation to the dysfunction of the vascular reserve, is the paradise lost? Arthritis Res Ther 27(1):107. https:\/\/doi.org\/10.1186\/s13075-025-03568-x","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"8478_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24044097","volume":"24","author":"BS Fioretto","year":"2023","unstructured":"Fioretto BS, Rosa I, Matucci-Cerinic M et al (2023) Current trends in vascular biomarkers for systemic sclerosis: a narrative review. Int J Mol Sci 24(4):4097. https:\/\/doi.org\/10.3390\/ijms24044097","journal-title":"Int J Mol Sci"},{"issue":"12","key":"8478_CR15","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1016\/S2665-9913(25)00251-6","volume":"7","author":"JD Pauling","year":"2025","unstructured":"Pauling JD, Allanore Y, Buch MH et al (2025) Exploiting a unified vascular framework to predict organ-specific complications and accomplish disease modification in systemic sclerosis. Lancet Rheumatol 7(12):e895\u2013e906. https:\/\/doi.org\/10.1016\/S2665-9913(25)00251-6","journal-title":"Lancet Rheumatol"},{"key":"8478_CR16","doi-asserted-by":"publisher","unstructured":"Luo H, Hu D, Wang X et al (2026) Integrated inflammatory-immune-nutritional signatures differentiate lung phenotypes in systemic sclerosis. Front Med (Lausanne). 13:1795461. Published 2026 Apr 14. https:\/\/doi.org\/10.3389\/fmed.2026.1795461","DOI":"10.3389\/fmed.2026.1795461"},{"key":"8478_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1841944","volume":"17","author":"H Luo","year":"2026","unstructured":"Luo H, Hu D (2026) Biomarker patterns across skin-lung-gut burden in systemic sclerosis. Front Immunol 17:1841944. https:\/\/doi.org\/10.3389\/fimmu.2026.1841944","journal-title":"Front Immunol"},{"issue":"11","key":"8478_CR18","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747\u20131755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"8478_CR19","doi-asserted-by":"publisher","unstructured":"Humbert M, Kovacs G, Hoeper MM et al (2023) 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 61(1):2200879. Published 2023 Jan 6. https:\/\/doi.org\/10.1183\/13993003.00879-2022","DOI":"10.1183\/13993003.00879-2022"},{"issue":"11","key":"8478_CR20","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1681\/ASN.0000000720","volume":"36","author":"Y Binois","year":"2025","unstructured":"Binois Y, Buob D, Meuleman MS et al (2025) Histologic features associated with kidney survival in scleroderma renal crisis. J Am Soc Nephrol 36(11):2201\u20132212. https:\/\/doi.org\/10.1681\/ASN.0000000720","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"8478_CR21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12016-022-08945-x","volume":"64","author":"A Cole","year":"2023","unstructured":"Cole A, Ong VH, Denton CP (2023) Renal disease and systemic sclerosis: an update on scleroderma renal crisis. Clin Rev Allergy Immunol 64(3):378\u2013391. https:\/\/doi.org\/10.1007\/s12016-022-08945-x","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"8478_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keag081","volume":"65","author":"AL Herrick","year":"2026","unstructured":"Herrick AL (2026) Assessing digital vasculopathy in systemic sclerosis. Rheumatology (Oxford) 65(2):keag081. https:\/\/doi.org\/10.1093\/rheumatology\/keag081","journal-title":"Rheumatology (Oxford)"},{"key":"8478_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.11.020","author":"W Lin","year":"2025","unstructured":"Lin W, Zhao Z, Jia C et al (2025) Shared and unique molecular signatures across different autoantibody groups in systemic sclerosis: a multiomics analysis. Ann Rheum Dis. https:\/\/doi.org\/10.1016\/j.ard.2025.11.020","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"8478_CR24","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1136\/ard-2023-225415","volume":"83","author":"M Huang","year":"2024","unstructured":"Huang M, Tabib T, Khanna D et al (2024) Single-cell transcriptomes and chromatin accessibility of endothelial cells unravel transcription factors associated with dysregulated angiogenesis in systemic sclerosis. Ann Rheum Dis 83(10):1335\u20131344. https:\/\/doi.org\/10.1136\/ard-2023-225415","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8478_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2026.104010","volume":"25","author":"C Campochiaro","year":"2026","unstructured":"Campochiaro C, Maltez N, Suliman Y et al (2026) Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: an initiative from the world Scleroderma Foundation digital ulcer ad hoc committee. Autoimmun Rev 25(3):104010. https:\/\/doi.org\/10.1016\/j.autrev.2026.104010","journal-title":"Autoimmun Rev"},{"issue":"9","key":"8478_CR26","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/rheumatology\/keae190","volume":"63","author":"TI Papadimitriou","year":"2024","unstructured":"Papadimitriou TI, Lemmers JMJ, van Caam APM et al (2024) Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile. Rheumatology (Oxford) 63(9):2525\u20132534. https:\/\/doi.org\/10.1093\/rheumatology\/keae190","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"8478_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/ard-2022-223237","volume":"82","author":"S Sanges","year":"2023","unstructured":"Sanges S, Rice L, Tu L et al (2023) Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis. Ann Rheum Dis 82(3):365\u2013373. https:\/\/doi.org\/10.1136\/ard-2022-223237","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8478_CR28","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.echo.2025.07.013","volume":"38","author":"R Osgueritchian","year":"2025","unstructured":"Osgueritchian R, Jani VP, Mombeini H et al (2025) Refining risk prediction in systemic sclerosis-associated pulmonary arterial hypertension. J Am Soc Echocardiogr 38(11):1064\u20131074. https:\/\/doi.org\/10.1016\/j.echo.2025.07.013","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"8478_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ph14050403","volume":"14","author":"B Ruaro","year":"2021","unstructured":"Ruaro B, Confalonieri M, Salton F et al (2021) The relationship between pulmonary damage and peripheral vascular manifestations in systemic sclerosis patients. Pharmaceuticals (Basel) 14(5):403. https:\/\/doi.org\/10.3390\/ph14050403","journal-title":"Pharmaceuticals (Basel)"},{"key":"8478_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2026.106819","author":"M Orlandi","year":"2026","unstructured":"Orlandi M, Verdina T, Santoro F et al (2026) Optical coherence tomography angiography: a window on systemic sclerosis microangiopathy. Eur J Intern Med. https:\/\/doi.org\/10.1016\/j.ejim.2026.106819","journal-title":"Eur J Intern Med"},{"issue":"15","key":"8478_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI177123","volume":"135","author":"D Saha","year":"2025","unstructured":"Saha D, Annadorai RK, Thannimangalath S et al (2025) Angiopoietin-like protein 2 mediates vasculopathy-driven fibrogenesis in a mouse model of systemic sclerosis. J Clin Invest 135(15):e177123. https:\/\/doi.org\/10.1172\/JCI177123","journal-title":"J Clin Invest"},{"issue":"2","key":"8478_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/23971983241256250","volume":"9","author":"F Marongiu","year":"2024","unstructured":"Marongiu F, Ruberto MF, Barcellona D (2024) Is anticoagulative therapy in systemic sclerosis to be reconsidered? J Scleroderma Relat Disord 9(2):81\u201385. https:\/\/doi.org\/10.1177\/23971983241256250","journal-title":"J Scleroderma Relat Disord"},{"key":"8478_CR33","doi-asserted-by":"publisher","unstructured":"Sanges S, Guerrier T, Duhamel A et al (2022) Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension. Front Immunol 13:954007. Published 2022 Jul 29. https:\/\/doi.org\/10.3389\/fimmu.2022.954007","DOI":"10.3389\/fimmu.2022.954007"},{"issue":"1","key":"8478_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27010197","volume":"27","author":"VE Contini","year":"2025","unstructured":"Contini VE, Queiroz ZAJ, Catanozi S et al (2025) Temporal dynamics of pulmonary fibrosis and immune dysregulation in a collagen V-driven systemic sclerosis model. Int J Mol Sci 27(1):197. https:\/\/doi.org\/10.3390\/ijms27010197","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8478_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-66974-4","volume":"16","author":"KM Matsuda","year":"2025","unstructured":"Matsuda KM, Chen YY, Ebata S et al (2025) Autoantibody landscape and functional role of anti-C-C motif chemokine receptor 8 autoantibodies in systemic sclerosis: post-hoc analysis of a B-cell depletion trial. Nat Commun 16(1):10872. https:\/\/doi.org\/10.1038\/s41467-025-66974-4","journal-title":"Nat Commun"},{"key":"8478_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1691988","volume":"16","author":"K Komura","year":"2025","unstructured":"Komura K (2025) The clinical utility of autoantibodies in systemic sclerosis: a review with a focus on cohort differences and standardization. Front Immunol 16:1691988. https:\/\/doi.org\/10.3389\/fimmu.2025.1691988","journal-title":"Front Immunol"},{"issue":"8","key":"8478_CR37","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s10067-024-07039-7","volume":"43","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Jin W, Zheng Z et al (2024) Prediction of prognosis in patients with systemic sclerosis based on a machine-learning model. Clin Rheumatol 43(8):2573\u20132584. https:\/\/doi.org\/10.1007\/s10067-024-07039-7","journal-title":"Clin Rheumatol"},{"issue":"3","key":"8478_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004240","volume":"10","author":"M Kuwana","year":"2024","unstructured":"Kuwana M, Avouac J, Hoffmann-Vold AM et al (2024) Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung disease. RMD Open 10(3):e004240. https:\/\/doi.org\/10.1136\/rmdopen-2024-004240","journal-title":"RMD Open"},{"issue":"2","key":"8478_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2026.104620","volume":"31","author":"SC Lee","year":"2026","unstructured":"Lee SC, Yu KH, Huang HC et al (2026) Reactive oxygen species driven immune inflammation in systemic sclerosis: mechanisms and emerging therapeutics. Drug Discov Today 31(2):104620. https:\/\/doi.org\/10.1016\/j.drudis.2026.104620","journal-title":"Drug Discov Today"},{"key":"8478_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1713221","volume":"17","author":"M Liu","year":"2026","unstructured":"Liu M (2026) The immune landscape of systemic sclerosis: from pathogenic mechanisms to precision therapeutic breakthroughs. Front Immunol 17:1713221. https:\/\/doi.org\/10.3389\/fimmu.2026.1713221","journal-title":"Front Immunol"},{"issue":"7","key":"8478_CR41","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/CIRCRESAHA.123.323299","volume":"134","author":"A Rius Rigau","year":"2024","unstructured":"Rius Rigau A, Li YN, Matei AE et al (2024) Characterization of vascular niche in systemic sclerosis by spatial proteomics. Circ Res 134(7):875\u2013891. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.323299","journal-title":"Circ Res"},{"issue":"11","key":"8478_CR42","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41577-024-01043-3","volume":"24","author":"M Nishide","year":"2024","unstructured":"Nishide M, Shimagami H, Kumanogoh A (2024) Single-cell analysis in rheumatic and allergic diseases: insights for clinical practice. Nat Rev Immunol 24(11):781\u2013797. https:\/\/doi.org\/10.1038\/s41577-024-01043-3","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"8478_CR43","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41584-025-01294-x","volume":"21","author":"JHW Distler","year":"2025","unstructured":"Distler JHW, Kuwana M, Assassi S et al (2025) Emerging therapies for the treatment of systemic sclerosis. Nat Rev Rheumatol 21(10):612\u2013625. https:\/\/doi.org\/10.1038\/s41584-025-01294-x","journal-title":"Nat Rev Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08478-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08478-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08478-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:05:58Z","timestamp":1791821158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08478-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":43,"alternative-id":["8478"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08478-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (No. 2026-E0248) and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No commercial editorial assistance was used. Any AI-assisted language editing was reviewed and verified by the authors, who take full responsibility for the accuracy and integrity of the manuscript.","order":2,"name":"Ethics","label":"Editorial support and AI disclosure","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No related congress abstract has been published previously.","order":3,"name":"Ethics","label":"Conference abstract disclosure","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":4,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}